GILEAD SCIENCES, INC.

13D and 13G Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.

Issuer % of Class Filed
Arcus Biosciences, Inc. 13D/A Amendment 7
RCUS · 03969F109
 24.7% 8/7/2026
Event 8/5/2026
Assembly Biosciences, Inc. 13D/A Amendment 4
ASMB · 045396108
 25.1% 5/27/2026
Event 5/22/2026
Arcellx, Inc. 13D/A Amendment 1
ACLX · 03940C100
 100.0% 4/28/2026
Event 4/28/2026
Arcellx, Inc. 13D
ACLX · 03940C100
 11.5% 2/23/2026
Event 2/23/2026
Xilio Therapeutics, Inc. 13G/A Amendment 3
XLO · 98422T100
 19.9% 2/12/2026
Event 12/31/2025
Cypherpunk Technologies Inc. 13G/A Amendment 1
CYPH · 52187K200
 0% 2/12/2026
Event 12/31/2025
Arcus Biosciences, Inc. 13D/A Amendment 6
RCUS · 03969F109
 25.6% 11/5/2025
Event 11/3/2025
Xilio Therapeutics, Inc. 13G/A Amendment 2
XLO · 98422T100
 19.9% 8/14/2025
Event 6/30/2025
Assembly Biosciences, Inc. 13D/A Amendment 3
ASMB · 045396108
 29.0% 8/12/2025
Event 8/8/2025
Arcus Biosciences, Inc. 13D/A Amendment 5
RCUS · 03969F109
 29.7% 7/15/2025
Event 7/13/2025
Kalaris Therapeutics, Inc. 13G/A Amendment 2
KLRS · 482929106
 3.9% 3/20/2025
Event 3/18/2025
Arcus Biosciences, Inc. 13D/A Amendment 4
RCUS · 03969F109
 35.0% 3/5/2025
Event 2/18/2025
Arcus Biosciences, Inc. 13D/A Amendment 4
RCUS · 03969F109
 35.0% 2/20/2025
Event 2/18/2025
Ikena Oncology, Inc. 13G/A Amendment 1
IKNA · 45175G108
 3.6% 2/13/2025
Event 12/31/2024
Galapagos NV 13D/A Amendment 4
LKFT · 36315X101
 29.9% 1/10/2025
Event 1/7/2025
Assembly Biosciences, Inc. 13D/A Amendment 2
ASMB · 045396108
 29.9% 12/23/2024
Event 12/19/2024
Xilio Therapeutics, Inc. 13G/A Amendment 1
XLO · 98422T100
 19.9% 12/19/2024
Event 12/18/2024